AID and Its Impact on Antibody Genetic Alteration

Data derived from the Science Watch/Hot Papers database and the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. M. Muramatsu et al., "Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme," Cell, 102:553-63, Sept.1, 2000. (Cited in 134 papers) P. Revy et al., "Activation-induced cytidine deaminase (AID) deficiency causes the aut

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Antibodies undergo three phases of genetic alteration. Researchers know that perhaps one billion different specificities of human antibodies are created from just 1,000 genes in the germline by shifting and reshifting various segments, called variability (V), diversity (D), and joining (J). These antibodies together recognize nearly every pathogen and toxin the body could encounter. Researchers know, too, that an antibody's affinity for its antigen tends to increase over the course of a response--a phenomenon known as affinity maturation--through a process called somatic hypermutation. SHM takes place in the lymph node germinal centers as B cells compete for limited antigen, with the ability to survive conferred only on those with the highest affinity.

A third genetic process, which also occurs in the germinal centers, is class switch recombination (CSR). In CSR, the molecule's constant (C) segment--encoding the stem of the Y-shaped antibody--is changed, conferring different functions on the antibody.

Coauthored by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Josh Roberts

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours